Acorah Software Products - Accounts Production 15.0.500 true true false true No description of principal activity 13 March 2023 31 March 2024 31 March 2024 14725644 Mr Mitul Patel Mr Kanwardeep Dhanoa Mr Sundar Raj Gopaul Mr Pravin Singh iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14725644 2023-03-12 14725644 2024-03-31 14725644 2023-03-13 2024-03-31 14725644 frs-bus:PrivateLimitedCompanyLtd 2023-03-13 2024-03-31 14725644 frs-bus:FilletedAccounts 2023-03-13 2024-03-31 14725644 frs-bus:Micro-entities 2023-03-13 2024-03-31 14725644 frs-bus:EntityHasNeverTraded 2023-03-13 2024-03-31 14725644 frs-bus:AuditExempt-NoAccountantsReport 2023-03-13 2024-03-31 14725644 frs-bus:Director1 2023-03-13 2024-03-31 14725644 frs-bus:Director2 2023-03-13 2024-03-31 14725644 frs-bus:Director3 2023-03-13 2024-03-31 14725644 frs-bus:Director4 2023-03-13 2024-03-31
Registered number: 14725644
Gorleston Pharma Ltd
Financial Statements
For the Period 13 March 2023 to 31 March 2024
Balance Sheet
Registered number: 14725644
31 March 2024
£
Current assets 4
NET CURRENT ASSETS 4
TOTAL ASSETS LESS CURRENT LIABILITIES 4
NET ASSETS 4
CAPITAL AND RESERVES 4

Notes

1. General Information
Gorleston Pharma Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14725644 . The registered office is 205 Plumstead Road,, Norwich, NR1 4AB.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 4
4
For the period ending 31 March 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Mr Mitul Patel
Director
16 April 2024